592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results

Friedman, C., Carvajal, R., Davar, D., Castanon, E., Ascierto, P., Calvo, E., O’Hara, M., Powell, S., Shapira-Frommer, R., Garralda, E., Renouf, D. J., Perets, R., Yunan, M., Ravindran, P., Hammell, A., O’Brien, S., Xu, K., Wilson, N., Jhatakia, A., … Gutierrez, M. (2022). 592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results. Regular and Young Investigator Award Abstracts, A620–A621. https://doi.org/10.1136/jitc-2022-sitc2022.0592
Authors:
Claire F. Friedman
Richard D. Carvajal
Diwakar Davar
Eduardo Castañón
Paolo A. Ascierto
Emiliano Calvo
Mark H. O’Hara
Steven Powell
Ronnie Shapira‐Frommer
Elena Garralda
Daniel J. Renouf
Ruth Perets
Mona Yunan
Palanikumar Ravindran
Amy Hammell
Shaun O’Brien
Ke Xu
Nicholas Wilson
Amy Jhatakia
Anandaroop Mukhopadhyay
Martin Gutierrez
Affiliated Authors:
Richard D. Carvajal
Publication Type:
Article
Unique ID:
10.1136/jitc-2022-sitc2022.0592
Publication Date:
Data Source:
OpenAlex

Record Created: